Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haris U Usman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Cardiovascular Medicine|September 26, 2008
New developments in anticoagulation for atrial fibrillationM Haris U Usman, Lawrence A Notaro, Harsh Patel, et al.
Vascular Medicine (London, England)|April 13, 2012
Targets and delivery methods for therapeutic angiogenesis in peripheral artery diseaseGeoffrey O Ouma, Rebecca A Jonas, M Haris U Usman, et al.
Vascular Medicine (London, England)|October 18, 2011
Personalized vascular medicine: individualizing drug therapyEmil M Degoma, Giovanni Rivera, Scott M Lilly, et al.
The American Journal of Cardiology|April 14, 2009
Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?M Haris U Usman, Lawrence A Notaro, Rangadham Nagarakanti, et al.
Heart & Lung : the Journal of Critical Care|December 2, 2006
Abciximab and fatal pulmonary hemorrhageM Haris U Usman, Manzoor A Shah, Tasbir ul-Islam, et al.
The American Journal of Medicine|July 31, 2012
Extended-release niacin acutely suppresses postprandial triglyceridemiaM Haris U Usman, Arman Qamar, Ramprasad Gadi, et al.
Archives of Dermatology|August 22, 2007
Age- and site-specific variation in the dermoscopic patterns of congenital melanocytic nevi: an aid to accurate classification and assessment of melanocytic neviLily Changchien, Stephen W Dusza, Anna Liza Chan Agero, et al.
Journal of the American Heart Association|November 7, 2012
Peroxisome Proliferator-Activated Receptor-α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked EndotoxemiaClaire K Mulvey, Jane F Ferguson, Jennifer Tabita-Martinez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Cardiovascular Medicine|September 26, 2008
New developments in anticoagulation for atrial fibrillationM Haris U Usman, Lawrence A Notaro, Harsh Patel, et al.
Vascular Medicine (London, England)|April 13, 2012
Targets and delivery methods for therapeutic angiogenesis in peripheral artery diseaseGeoffrey O Ouma, Rebecca A Jonas, M Haris U Usman, et al.
Vascular Medicine (London, England)|October 18, 2011
Personalized vascular medicine: individualizing drug therapyEmil M Degoma, Giovanni Rivera, Scott M Lilly, et al.
The American Journal of Cardiology|April 14, 2009
Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?M Haris U Usman, Lawrence A Notaro, Rangadham Nagarakanti, et al.
Heart & Lung : the Journal of Critical Care|December 2, 2006
Abciximab and fatal pulmonary hemorrhageM Haris U Usman, Manzoor A Shah, Tasbir ul-Islam, et al.
The American Journal of Medicine|July 31, 2012
Extended-release niacin acutely suppresses postprandial triglyceridemiaM Haris U Usman, Arman Qamar, Ramprasad Gadi, et al.
Archives of Dermatology|August 22, 2007
Age- and site-specific variation in the dermoscopic patterns of congenital melanocytic nevi: an aid to accurate classification and assessment of melanocytic neviLily Changchien, Stephen W Dusza, Anna Liza Chan Agero, et al.
Journal of the American Heart Association|November 7, 2012
Peroxisome Proliferator-Activated Receptor-α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked EndotoxemiaClaire K Mulvey, Jane F Ferguson, Jennifer Tabita-Martinez, et al.
Pageof 1